Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported
TUESDAY, Sept. 22, 2026-- For patients receiving immune checkpoint inhibitors (ICIs), rheumatic immune-related adverse events (rh-irAEs) are usually moderate or severe, with more than one-third leading to permanent ICI discontinuation, according...
Read more »
Pharmaceutical news
Gene Mutation Identified That Increases Lung Cancer Risk
What Happens When You Can’t See A Family Doctor Regularly?
Surveillance Colonoscopy at Five Years After Adenoma Removal Noninferior to Three Years
Mammography Trials Yield Excess-Incidence Patterns Consistent With Low Overdiagnosis
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL
Cirrhosis Can Recur After Liver Transplant
Kratom Cases Climb Sharply Across The US
MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds
Cardiovascular Health And Exercise: How Much Aerobic Activity Do You Really Need?
Mindfulness, Tai Chi Can Ease Pain, Fatigue Among Cancer Survivors
Interest In Dementia Vaccine High In U.S., Survey Finds
Marathons Safe For People With Type 1 Diabetes, Study Says
Parents Say They Don't Know Much About E-Bikes, Poll Finds
